Legal Opinion of Guangdong Cinda Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Kangmei Pharmaceutical Co., Ltd.
Announcement of Resolutions of Kangmei Pharmaceutical\'s 2024 First Extraordinary General Meeting of Shareholders
Kangmei Pharmaceutical Stock Trading Risk Warning Notice
Announcement on abnormal fluctuations in Kangmei Pharmaceutical\'s stock trading
Reply to the inquiry letter on abnormal fluctuations in Kangmei Pharmaceutical\'s stock trading
Kangmei Pharmaceutical 2024 First Extraordinary General Meeting of Shareholders Meeting Information
Kangmei Pharmaceutical\'s announcement on holding a performance briefing for the third quarter of 2024
Kangmei Pharmaceutical: Announcement of Resolutions of the Fourth Interim Meeting of the 9th Board of Directors of Kangmei Pharmaceutical in 2024
Kangmei Pharmaceutical: Notice of Kangmei Pharmaceutical on Convening the 2024 First Extraordinary General Meeting of Shareholders
Kangmei Pharmaceutical: Kangmei Pharmaceutical\'s announcement on selecting and hiring an accounting firm
Kangmei Pharmaceutical: Announcement of Resolutions of the Third Interim Meeting of the 9th Supervisory Board of Kangmei Pharmaceutical in 2024
Kangmei Pharmaceutical: Kangmei Pharmaceutical Third Quarter Report 2024
Kangmei Pharmaceutical\'s Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Announcement of Resolutions of the Fourth Interim Meeting of the 9th Board of Directors of Kangmei Pharmaceutical in 2024
Announcement of Resolutions of the Third Interim Meeting of the 9th Board of Supervisors of Kangmei Pharmaceutical in 2024
Kangmei Pharmaceutical Report for the Third Quarter of 2024
Kangmei Pharmaceutical\'s announcement on selecting and hiring an accounting firm
Kangmei Pharmaceutical: Kangmei Pharmaceutical\'s announcement on progress in the execution of subsidiary lawsuits (3)
Kangmei Pharmaceutical\'s announcement on progress in the execution of subsidiary lawsuits (3)
Kangmei Pharmaceutical\'s announcement on holding the 2024 semi-annual results briefing
No Data